\n
1 \u03c4\u03bf\u03c5 4<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
Professor Yoram Weiss, Director General of the Hadassah Medical Organization, discussed the use of artificial intelligence in developing new treatments and identifying the most appropriate therapy for each patient.<\/p>\n
Cardiologist Dr Lakis Anastasiades highlighted the opportunities for knowledge exchange and collaboration with Hadassah specialists, particularly in the field of cardiology.<\/p>\n
Yigal Molad Hayo, President of Hadassah Medical Limited, outlined the prospects arising from Hadassah\u2019s presence in Cyprus, identifying the establishment of a hospital in cooperation with local partners as a long-term objective.<\/p>\n
Professor Ram Mosheiff focused on advances in orthopaedics, including robotics and research into cartilage regeneration, while Professor Aron Popovtzer discussed efforts to develop personalised cancer immunotherapies.<\/p>\n
Professor Offer Amir highlighted the use of sensors in monitoring heart failure patients, as well as ongoing research into the microbiome.<\/p>\n
Dr Panayiota Petrou addressed the development of new biomarkers, identified through MRI scans and blood tests, aimed at improving the monitoring and management of multiple sclerosis.<\/p>\n